000 | 01562 a2200433 4500 | ||
---|---|---|---|
005 | 20250517091102.0 | ||
264 | 0 | _c20180702 | |
008 | 201807s 0 0 eng d | ||
022 | _a1552-4957 | ||
024 | 7 |
_a10.1002/cyto.b.21374 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJohansson, Pegah | |
245 | 0 | 0 |
_aValidation of a flow cytometry-based detection of γ-H2AX, to measure DNA damage for clinical applications. _h[electronic resource] |
260 |
_bCytometry. Part B, Clinical cytometry _c11 2017 |
||
300 |
_a534-540 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Validation Study | ||
650 | 0 | 4 |
_aAminoglycosides _xpharmacology |
650 | 0 | 4 |
_aAtaxia Telangiectasia _xgenetics |
650 | 0 | 4 |
_aChromones _xpharmacology |
650 | 0 | 4 |
_aDNA _xdrug effects |
650 | 0 | 4 |
_aDNA Breaks, Double-Stranded _xdrug effects |
650 | 0 | 4 |
_aDNA Repair _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Radiation |
650 | 0 | 4 |
_aEnediynes _xpharmacology |
650 | 0 | 4 |
_aFlow Cytometry _xmethods |
650 | 0 | 4 | _aGamma Rays |
650 | 0 | 4 |
_aHistones _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
650 | 0 | 4 |
_aMorpholines _xpharmacology |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 | _aPrimary Cell Culture |
650 | 0 | 4 |
_aPyrones _xpharmacology |
700 | 1 | _aFasth, Anders | |
700 | 1 | _aEk, Torben | |
700 | 1 | _aHammarsten, Ola | |
773 | 0 |
_tCytometry. Part B, Clinical cytometry _gvol. 92 _gno. 6 _gp. 534-540 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/cyto.b.21374 _zAvailable from publisher's website |
999 |
_c25908322 _d25908322 |